IVIryna H. Vasylieva

Iryna H. Vasylieva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iryna H. Vasylieva has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neuroinflammation: molecular mechanisms, triggers, and biomarkers for clinical stratification

    by Mykhailo V. Khyzhnyak, Iryna H. Vasilyeva, Yuriy G. Gafiychuk

    Neuroinflammation is increasingly regarded as a key factor in the progression of neurological disorders. At the same time, in clinical practice it is often interpreted in an overly simplified manner and reduced to nonspecific activation of inflammatory responses. Objective: to integrate contemporary molecular and cellular evidence in order to conceptualize neuroinflammation as a context-dependent and stage-determined biological program, and to delineate mechanistic determinants relevant to biomarker interpretation and therapeutic stratification. Materials and methods: A narrative analysis of contemporary experimental, translational, and clinical studies focusing on innate protective mechanisms of the central nervous system was performed. The review emphasizes PRR-mediated recognition of pathogen-associated and damage-associated molecular patterns, intracellular inflammatory signaling pathways (NF-κB, MAPK, JAK/STAT, inflammasome complexes), mechanisms of inflammatory termination and resolution, and the regulatory role of the blood–brain barrier (BBB). Particular attention was given to data on glial cell biology, neurovascular unit signaling, biomarker profiles in cerebrospinal fluid and blood, and disease-specific neuroinflammatory phenotypes. Results: The synthesized data indicate that neuroinflammation is not a uniform pathological state but represents a dynamic, multicomponent program shaped by the balance between initiation, amplification, resolution, and chronic persistence of inflammatory responses. Two closely interrelated components can be distinguished. The first is a resident innate neuroinflammatory program, predominantly mediated by microglia, astrocytes, and endothelial cells through PRR-dependent protective signaling mechanisms. The second is an adaptive immune component characterized by infiltration of peripheral immune cells and the development of antigen-specific responses. Disruption of resolution mechanisms, insufficient clearance of damage-associated signals, and sustained PRR activation promote the development of chronic neuroinflammation and neurodegenerative changes. The functional state of the BBB emerges as a critical modifier of neuroinflammatory dynamics, directly affecting biomarker interpretation, therapeutic access and clinical response. Conclusions: Neuroinflammation should be conceptualized as a potentially modifiable biological program rather than a fixed pathological entity. Effective diagnostic and therapeutic strategies require context- and stage-specific stratification that takes into account the dominant inflammatory component, disease phase, etiological triggers, and the functional state of the BBB. Approaches aimed at limiting inflammatory amplification, restoring resolution mechanisms, and stabilizing barrier function are likely to offer greater translational potential than nonspecific anti-inflammatory suppression.

  • Platelet-rich fibrin gel as an in situ bioreactor supporting serotonergic neuron survival and neural lineage gene expression in rat mesenchymal stem cells

    by Oleksandr Usenko, Mykhailo Khyzhniak, Iryna Vasylieva, Nataliia Chopyk, Nataliia Oleksenko, Olha Tsiubko

    Platelet-derived biomaterials are increasingly used in regenerative medicine as bioactive scaffolds capable of modulating cell survival, lineage-associated molecular responses, and tissue repair. Fibrin gels enriched with platelet-derived growth factors represent a promising microenvironment for neural tissue engineering, as they may support neuronal survival and promote neural lineage-associated changes in stem cells. Objective. To evaluate the ability of a platelet-enriched fibrin gel derived from human platelet-rich plasma to function as a bioactive three-dimensional microenvironment supporting survival and morphogenesis of serotonergic neurons and neural lineage-associated changes in mesenchymal stem cells (MSCs). Materials and methods. A platelet-enriched fibrin gel matrix was generated from platelet-rich plasma following activation with a silica-based coagulation activator. A platelet-enriched fibrin gel matrix derived from human platelet-rich plasma served as a three-dimensional culture platform for bone marrow-derived MSCs from newborn rats and for primary serotonergic cells isolated from raphe nuclei. Cultures were maintained for up to 14 days. Serotonin production was assessed using ELISA, while expression of genes associated with serotonergic phenotype maintenance (Pet1, Nkx2-2, Tph2, Slc6a4) and neural lineage-associated molecular changes (Nes, Tubb3, Gfap, Olig2) was analyzed by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). Results. Raphe-derived cells cultured within the platelet-enriched fibrin gel matrix demonstrated active neurite extension and formation of neuronal networks. Maintenance of a serotonergic phenotype was supported by histochemical detection of serotonin and by persistence of Pet1, Nkx2-2, Tph2, and Slc6a4 expression during the culture period. MSCs cultured within the matrix in the presence of neuroinductive factors (retinoic acid, NGF, and BDNF) exhibited morphological features of neural-like cells and increased expression of early neural (Nes), neuronal (Tubb3), astroglial (Gfap), and oligodendroglial (Olig2) markers compared with control cultures. These findings indicate that platelet-enriched fibrin gel functions as a bioactive three-dimensional microenvironment supporting neuronal survival and neural lineage-associated molecular changes in MSCs and may serve as an in situ bioreactor-like platform for modeling neural regeneration in vitro. Conclusions. The platelet-enriched fibrin gel matrix provided a bioactive three-dimensional microenvironment that supported survival of serotonergic cells and modulated neural marker expression in MSCs under neuroinductive conditions. These findings are consistent with neural lineage-associated molecular responses, although additional quantitative and functional validation is required to confirm mature neural differentiation.

  • Open Access

    PLATELET-RICH PLASMA AND PLATELET FIBRIN: STANDARDIZED PREPARATION PROTOCOLS, MECHANISMS OF ACTIVATION, STORAGE STABILITY, AND REGULATORY FRAMEWORKS

    by Mykhailo Khyzhnyak, Iryna Vasilyeva, Oleksandr Potapov, Oleksandr Tsyndrenko, Yuri Gafiychuk

    Objective. To summarize current methods for obtaining platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), their biological properties, activation protocols, and regulatory aspects of clinical application. Methods. A comprehensive analysis of recent literature on the preparation, standardization, and clinical use of platelet-derived biomaterials was performed. Special attention was given to two-step centrifugation protocols for producing pure platelet-rich plasma (P-PRP), low-speed centrifugation techniques for injectable PRF (i-PRF), and methods for constructing fibrin-based matrices (P-PRF). Results. Platelet-derived biomaterials represent a concentrated source of growth factors (PDGF, TGF-β, VEGF, IGF-1, EGF, FGF, HGF) that promote tissue regeneration, angiogenesis, and immunomodulatory effects. The efficacy of PRP/PRF depends on donor hematological parameters, centrifugation settings, activation strategies, and delivery methods. This review outlines optimal platelet concentration ranges, discusses the rationale for anticoagulant selection, and describes quality control methods as well as classification systems (PAW, DEPA, MARSPILL). Regulatory aspects of PRP application in Ukraine are also highlighted, including cases in which GMP certification is mandatory. Conclusion. PRP and PRF occupy a prominent position in regenerative medicine; however, the lack of standardized protocols and unified guidelines hampers the comparability of clinical outcomes. Future development in this field requires methodological harmonization, large-scale clinical studies, and the implementation of GMP standards in commercial production.

  • Open Access

    Platelet-rich plasma in discogenic pain: therapeutic potential of multifactorial action

    by Mykhailo V. Khyzhnyak, Iryna H. Vasylieva, Yuriy H. Hafiychuk

    Intervertebral disc degeneration (IVDD) is one of the leading causes of chronic low back pain and disability. The key pathogenetic mechanism of IVDD is chronic inflammation, which leads to extracellular matrix catabolism and the death of disc cells. It has been established that these changes are based on the activation of pro-inflammatory signaling cascades, particularly NF-κB, MAPK, and JAK/STAT pathways, as well as the induction of caspase-dependent apoptosis. Objective: To summarize current understanding of the molecular signaling pathways involved in degenerative processes within the intervertebral disc, and to elucidate the mechanisms of action of platelet-rich plasma (PRP) components capable of modulating these pathways. Materials and methods: A comprehensive analysis of contemporary experimental and clinical studies was performed to evaluate the effects of the main growth factors present in PRP (TGF-β, PDGF, IGF-1, FGF, CTGF, EGF, HGF) on signaling pathways in intervertebral disc cells associated with catabolism, apoptosis, and inflammation. Results: PRP-derived factors exert their effects through activation of the Smad, PI3K/AKT, MAPK, and JAK/STAT pathways while attenuating NF-κB activity, leading to decreased levels of pro-inflammatory cytokines (IL-1β, TNF-α) and metalloproteinases (MMPs, ADAMTS). These effects are accompanied by enhanced expression of type II collagen and aggrecan, stabilization of the extracellular matrix, restoration of tissue homeostasis and increased cell proliferation. Conclusions: PRP therapy demonstrates considerable potential as a pathogenetically oriented regenerative strategy for the treatment of IVDD. Its efficacy arises from a multimodal influence on inflammatory, catabolic, and apoptotic pathways. Further clinical research is warranted to standardize treatment protocols and confirm the long-term therapeutic effectiveness of PRP.

  • Open Access

    Evaluation of the efficacy of combined vitamin D3 and K2 therapy in reducing implant-associated complication risk and improving spinal fusion stability

    by Oleksii S. Nekhlopochyn, Iryna G. Vasylieva, Nataliia G. Chopyk, Vadim V. Verbov, Ievgen V. Cheshuk, Milan V. Vorodi

    In the last decade, the use of implants in spinal surgery has significantly increased, particularly interbody devices and transpedicular fixators. This trend has necessitated refining approaches aimed at preventing intra- and postoperative complications. A key factor influencing the effectiveness of stabilization procedures is bone mineral density (BMD). Objective: To investigate the relationship among vitamin D levels, BMD, and the incidence of implant-related failures in patients who have undergone stabilization procedures on the spine, as well as to evaluate the role of postoperative correction of vitamin D₃ and K2 deficiencies in enhancing fixation stability and reducing complication risks. Materials and Methods: A retrospective single-center cohort study was conducted in specialized departments of Romodanov Neurosurgery Institute NAMS of Ukraine, from January 2023 to December 2024. A total of 250 patients who underwent spinal surgery with the use of transpedicular screws and/or interbody implants were analyzed with respect to their age, sex, body mass index, serum vitamin D (25-(OH)D₃) levels, and BMD (according to computed tomography data). Original grading scales were used to evaluate implant-related complications. Postoperative correction of vitamin D deficiency was carried out using “Solemax®” (vitamin D₃, vitamin K2, and ω-3 polyunsaturated fatty acids). Results: A high prevalence of vitamin D deficiency and reduced BMD was recorded among patients undergoing elective stabilization surgeries on the spine. A significant correlation was detected between 25-(OH)D₃ levels and bone tissue status. After 4 months of “Solemax®” administration, all patients achieved reference 25-(OH)D3 levels, indicating the effectiveness of the therapy. In the correction group, an increase in BMD was observed, whereas in the comparison group, BMD values decreased. The incidence of implant-related complications was statistically reduced: the risk of screw loosening decreased by 69.84% over the first 6 months and by 85.06% over one year, while the risk of interbody implant migration declined by 56.2% and 64.7%, respectively. Conclusions: The stability of spinal fusion is more contingent upon the adaptive response of bone tissue to implantation than on absolute BMD values. The use of a balanced combination of vitamins D₃ and K2 contributes to enhanced fixation stability and a lower risk of postoperative complications.


  • Open Access

    Polymorphisms of the collagen genes of the fibrous ring rs1800012, rs2276454, rs1793953, and the VDR gene rs2228570 with intervertebral disc degeneration

    by Ye.H. Pedachenko, I.H. Vasylieva, M.V. Khyzhnyak, N.G. Chopyck, O.I. Tsyubko, A.B. Dmytrenko, T.A. Makarova, O.I. Troyan, T.A. Ksenzov

    Background. Spinal diseases cause significant disability, with genetic factors influencing up to 70 % of cases. This study purposed to examine the association of polymorphisms of COL1A1rs1800012, COL2A1rs2276454, COL2A1rs1793953 (collagen genes), and VDRrs2228570 with L4-L5, L5-S1, C5-C7 with intervertebral disc degeneration among ethnic Ukrainians. Materials and methods. The study included 90 individuals with L5-S1 disc degeneration, 50 — with L4-L5 degeneration, 30 — with C5-C7, and 66 controls without disc degeneration. Applied Biosystems (USA) kits were used for genotyping. Statistical analysis was performed using SNPStats. Results. There was an association between the C/C genotype and L5-S1 disc degeneration in men (odd ratio (OR) was 2.255, 95% confidence interval (CI): 1.089–4.670; χ2 = 4.905; p = 0.027), whereas the C/T genotype may have a protective effect (OR = 0.418, 95% CІ: 0.217–0.802; χ2 = 6.689, p = 0.009). The C/T genotype may also have protective significance for C5-C7 disc degeneration in men: its occurrence was higher among men in the control group compared to women (OR = 3.85, 95% CІ: 1.086–13.648; χ2 = 4.67; p = 0.031). The G/A COL2A1rs2276454 variant may have a protective effect on the L5-S1 disc (OR = 3.50, 95% CІ: 1.26–9.72; χ2 = 6.02; p = 0.015). The pair of alleles COL2A1rs2276454/COL2A1rs1793953 were linked to degenerative changes of the L4-L5 disc in the case group (p = 0.001); COL1A1rs1800012/VDRrs2228570 and COL2A1rs1793953/VDRrs2228570 were linked to degenerative changes in the C5-C7 disc. Conclusions. The C/C VDRrs2228570 genotype in men was associated with L5-S1 intervertebral disc degeneration. The T/C VDRrs2228570 genotype may have a protective significance for men with L5-S1 and C5-C7 degeneration. The COL2A1rs2276454 variant may have a protective effect against the development of L5-S1 degenerative changes in men. The allele pairs COL1A1rs1800012/VDRrs2228570, COL2A1rs1793953/VDRrs2228570, and COL2A1rs2276454/COL2A1rs1793953 were associated with C5-C7 degeneration, while the COL2A1rs2276454/COL2A1rs1793953 pair were associated with L4-L5 degeneration.

  • Open Access

    Molecular Characteristics of Blood Serum After Covid-19 Vaccination in a Remote Period

    by Y.E. Pedachenko, I.G. Vasilieva, N.G. Chopik, O.I. Tsiubko, N.P. Oleksenko, A.B. Dmytrenko, T.A. Makarova, I.M. Shuba

    COVID-19 is a dangerous disease with long-lasting consequences. Vaccination contributes to the accumulation of neutralizing anti-S IgG antibodies, reducing the incidence of COVID-19 and its complications. However, in some individuals, the inflammatory process can persist for an indefinite period and lead to a wide range of dysfunctions. The current task is to investigate molecular markers for their detection. The aim of this study is to examine the levels of anti-S IgG antibodies, lactate, glucose, lactate dehydrogenase, and C-reactive protein in the peripheral blood of individuals who have and have not been affected by COVID-19 after vaccination. The research subject is venous blood. Among 547 employees of the Neurosurgery Institute (481 vaccinated against COVID-19 and 66 unvaccinated individuals), levels of anti-S IgG antibodies were investigated, as well as levels of lactate, lactate dehydrogenase, glucose, and C-reactive protein. At the time of the study, among 372 individuals, 16 months had passed from the first vaccination, and 12 months had passed from the second vaccination; in 21 individuals, 12 months had passed after a single vaccination, and in 88 individuals, 16 months had passed from the first vaccination, 12 months from the second, and 6 months from the third vaccination. Methods. Quantitative determination of IgG antibodies to the S protein of the SARS-CoV-2 virus. Confirmation of COVID-19 using the RT-PCR method (Allplex 2019-nCoV kit, SeeGene, Korea). Levels of lactate, lactate dehydrogenase, glucose, and C-reactive protein were determined using reagents from BioSystems (Spain). Statistical analysis of the obtained data was performed using Jamovi software (USA) and the following criteria: χ2 ‒ Kruskal-Wallis, W ‒ Dwass-Steel-Critchlow-Fligner (DSCF), χ2 ‒ Pearson, t ‒ Student, rs ‒ Spearman, τb ‒ Kendall. A statistically significant difference was considered at p < 0.05. Results. The level of anti-S IgG antibodies to the SARS-CoV-2 virus was higher in vaccinated individuals compared to unvaccinated individuals (Kruskal-Wallis χ2=14.09; p < 0.001). A higher level of antibodies to the S protein of the virus was observed when using the Comirnaty vaccine compared to vaccination with Moderna, AstraZeneca, Pfizer, and CoronaVac (Dwass-Steel-Critchlow-Fligner (DSCF): W 4.26, p=0.002; W 4.62, p=0.010; W 4.84, p=0.006, respectively). Vaccination reduces the likelihood of contracting the disease by 1.84 times (Odds Ratio (OR) 1.84; 95% Confidence Interval (CI) 1.02‒3.30; χ2=4.129; p=0.043). However, no statistically significant dependence on the prevention of COVID-19 incidence based on the type of vaccines used was found (Kruskal-Wallis χ2=2.072; p=0.72). A statistically significant difference in C-reactive protein levels is observed between groups with early mild complications and early moderate-severity complications (DSCF: W=4.193, p=0.009). A statistically significant difference in LDH levels is noted between individuals without chronic diseases and those with chronic diseases at the time of the study (Kruskal-Wallis χ2=6.08, p=0.014). In individuals vaccinated against the SARS-CoV-2 virus, a positive correlation is found between the levels of C-reactive protein and lactate dehydrogenase (Kendall's τb 0.134, p < 0.001). The mean levels of lactate among individuals with mild, moderate, and severe forms of COVID-19 are higher than the reference mean; similarly, the mean levels of glucose in these same groups are higher than the reference mean. A positive correlation exists between the levels of lactate and glucose among individuals vaccinated against the SARS-CoV-2 virus (Kendall's τb 0.082, p < 0.01). Conclusions. Vaccination contributes to an increase in antibody levels. The level of antibodies after the third vaccination exceeded the levels after the first (Dwass-Steel-Critchlow-Fligner (DSCF): W 4.42, p=0.005) and second vaccinations (W 4.24, p=0.008). Vaccination reduces the likelihood of COVID-19 infection by 1.84 times (Odds Ratio ‒ 1.84; 95% Confidence Interval 1.02‒3.30; Pearson χ2=4.129; p=0.043). The frequency of COVID-19 incidence is not dependent on the type of vaccine used: AstraZeneca, Comirnaty, CoronaVac, Moderna, Pfizer (Kruskal-Wallis χ2=2.072; p=0.723), and the level of antibodies in the vaccinated individuals' serum. In the post-COVID-19 remote period, regardless of vaccination status, various complications are observed. However, among the vaccinated, the number of individuals without complications or with minimal complications is greater than in the unvaccinated group, while the number of individuals with early and severe complications is lower (Kruskal-Wallis χ2=6.127; p=0.047). A high level of C-reactive protein (DSCF: W=4.19, p=0.009), a tendency toward increased levels of lactate dehydrogenase (DSCF: W=3.27, p=0.054), elevated levels of lactate (2.17+1.23, t=3.34; p=0.002), and glucose (6.06+0.048, t=10.54; p < 0.001) indicate that after recovering from COVID-19, regardless the type of vaccines used, in individuals with distant symptoms there are metabolic changes that are signs of a chronic inflammatory process. Individuals with chronic diseasees show an increase in the level of lactate dehydrogenase (χ2=6.08; p=0.014) and a tendency toward increased levels of C-reactive protein (χ2=3.74; p=0.053). Molecular markers of inflammation such as increased levels of lactate, glucose, C-reactive protein, and lactate dehydrogenase are informative for identifying individuals with an inflammatory process in the post-COVID-19 remote period.


  • Open Access

    Association of COL2A1rs2276454, rs1793953, COL9A1rs1135056, COL11A1rs1676486 structure-forming collagens of the nucleus pulposus with degeneration of intervertebral discs L5-L4, L5-S1

    by Ye. H Pedachenko, I H Vasylieva, M V Khyzhniak, O S Halanta, N H Chopyk, O I Tsiubko, A B Hriazov, O S Nekhlopochyn, T A Ksenzov, A B Dmytrenko, et al.

    Aim. The purpose of the work was to determine the relationship between degenerative changes of the L5-S1 and L4-L5 intervertebral discs with collagen mononucleotide variants COL2A1rs2276454, rs1793953, COL9A1rs1135056, COL11A1rs1676486 among ethnic Ukrainians. Materials and methods. The following subjects were investigated: 90 persons of the case group with degeneration of the intervertebral disc L5-S1; 50 persons of the case group with degeneration of the intervertebral disc L4-L5; 66 people of the control group. The object of the study was the venous blood of patients with degenerative lesions of the intervertebral discs and healthy donors. Venous blood was obtained as a result of venipuncture. Typing of COL2A1rs2276454, COL2A1rs1793953, COL9A1rs1135056, COL11A1rs1676486 was performed using the Tag Man Universal PCR Master Mix kit (Applied Biosystems, USA) and Tag Man SNP Genotyping Assays for the determination of polymorphisms (Applied Biosystems, USA). The research was carried out by specialists in the field of molecular biology and biochemistry of the Department of Neurobiochemistry of the SI “Romodanov Neurosurgery Institute, National Academy of Medical Sciences of Ukraine”, using the CFX96 device (Bio-Rrad, USA). Certificate of determination of measuring capabilities No. PT-322/21 from 07/28/2021 to 08/27/2023. Results. COL2A1rs2276454 may have a protective value for the development of degeneration of the intervertebral disc L5-S1 among men (OR (95 % CI): 0.27 (0.10–0.80), χ2 = 6.02, P = 0.015). Genotype C/T (COL9A1rs1135056) is 3.25 times more common among male patients with degeneration of the intervertebral disc L5-S1 in comparison with the female case group (OR (95 % CI): 3.25 (1.20–8.84), χ2 = 5.50, P = 0.02). The presence of the genotype G/A (COL11A1rs1676486) in the general group of patients with degeneration of the intervertebral disc L5-S1 is observed 5.46 times more often among male patients (OR (95 % CI): 5.46 (1.60–18.47), χ2 = 8.29, P = 0.004); G/A is registered 4.17 times more often among men compared to the group of women (OR (95 % CI): 4.17 (1.070–16.82), χ2 = 4.17, P = 0.04). Comparison of the odds of observing the genotype G/G, G/A, AA in the group of men with degeneration of the intervertebral disc L5-S1 showed a statistically significant 4.06 times predominance of the genotype G/A (OR (95 % CI): 4.06 (1.23–13.38), χ2 = 4.17, P = 0.04). The most probable model of heredity for COL11A1rs1676486 is dominant OR (95 % CI): 2.08 (1.03–4.21), χ2 = 4.26, P = 0.04. Associations of COL2A1rs2276454, rs1793953, COL9A1rs1135056, COL11A1rs1676486 structure-forming collagens of the gelatinous nucleus with degeneration of L5-L4 intervertebral discs were not detected. Conclusions. The COL2A1rs2276454 may be protective for the development of L5-S1 intervertebral disc degeneration in men (OR (95 % CI): 0.27 (0.10–0.80), χ2 = 6.02, Р = 0.015). COL2A1rs1793953 is not associated with degeneration of intervertebral discs L4-L5, L5-S1. С/T COL9A3rs1135056 genotype is associated with L5-S1 intervertebral disc degeneration among males (OR (95 % CI): 3.25 (1.20–8.84), χ2 = 5.50, Р = 0.02) compared with L5-S1 females. G/A COL11A1rs1676486 genotype is associated with L5-S1 intervertebral disc degeneration among male patients (OR (95 % CI): 5.46 (1.60–18.47), χ2 = 8.29, Р = 0.004) and compared to female patients (OR (95 % CI): 4.17 (1.07–16.82), χ2 = 4.17, Р = 0.04). The type of inheritance COL11A1rs1676486 is dominant.

  • Open Access

    Association of COL11A1 C4603T polymorphism with the risk of cervical and lumbar disc herniation

    by Ye. H. Pedachenko, I. H. Vasylieva, M. V. Khyzhnyak, O. S. Halanta, N. H. Chopyk, О. І. Tsiubko, A. В. Hriazov, O. S. Nekhlopochyn, Т. A. Ksenzov, A. B. Dmytrenko, et al.

    Aim. To evaluate the association of COL11A1 gene C4603T polymorphism with the risk of cervical and lumbar disc herniation among Ukrainian people. Materials and methods. In total, 97 patients (48 women and 49 men with a mean age of 34.49 ± 6.75 years) with lumbar and cervical disc herniation and 60 (30 women and 30 men with a mean of 35.00 ± 6.51 years) control subjects were included in the study. All participants underwent T2-weighted magnetic resonance imaging (MRI). Single nucleotide polymorphism С4603Т (rs1676486) of COL11A1 gene was detected by real-time polymerase chain reaction using Tag Man Universal PCR Master Mix (Applied Biosystems, USA) and Tag Man SNP Genotyping Assays (Applied Biosystems, USA). Results. The study revealed the association of the COL11A1 gene C4603T polymorphism with a risk of lumbar L5-S1 herniation in the dominant (OR = 3.20; 95 % CI (1.34–7.50); P < 0.008) and multiplicative models (OR = 2.82; 95 % CI (1.34–5.93); P < 0.006). A statistical association of the polymorphism with lumbar L4-L5 herniation was not found. Carriers of the 4603Т allele had a four-fold higher risk of cervical herniation in the dominant model (OR =4.00; 95 % CI (1.37–11.79); P < 0.01), and three-fold higher – in the multiplicative model (OR = 3.12; 95 % CI (1.26–7.69); P < 0.05). Conclusions. The study has shown the statistically significant association of the COL11A1 C4603T polymorphism with cervical and lumbar disc herniation among Ukrainian people. The 4603T allele presence should be considered when a sports career planning or occupational choice related to a heavy load on the cervical or lumbar spine.

  • An analysis of association FGB and eNOS3 genes polymorphisms with intracranial hemorrhagic and atherothrombotiс ischemic stroke

    by Vitalii Tsymbaliuk, Iryna Vasylieva, Mykhaylo Kostiuk, Natalia Chopyk, Natalia Oleksenko, Olena Galanta, Olha Tsiubko, Tetiana Makarova, Anzhela Dmytrenko, Iryna Shuba

    European Stroke Organisation (ESO) in cooperation with the Stroke Alliance for Europe (SAFE) prepared a 2018 – 2030 European Stroke Action Plan. One of priority items of this plan is taking to account human polygenetic risk profiles. NO-synthase3 (eNOS3) and beta-fibrinogen (FGB) polymorphisms are clinically significant for cardiovascular diseases and ethnically different. Objective: to estimate the association оf polymorphisms Т-786С, G894T 4b/4a of eNOS3 gene and С-148Т polymorphism of FGB gene with a risk of ischemic atherothrombotiс stroke and intracranial hemorrhagic stroke of Ukrainian people. Materials and methods. 102 patients with atherothrombotiс ischemic stroke, 56 patients with intracranial hemorrhagic stroke and 102 healthy control subjects were included in the study. Single nucleotide polymorphisms were detected by polymerase chain reaction followed by restrictases digestion and VNTR polymorphism gene was determined by allele-specific PCR method. Results. The study revealed association of C-148T polymorphism eNOS3 gene in dominant (OR = 2,276; 95 % CI:1,298– 4,152) and multiplicative (OR = 2,322; 95 % CI:1,322–4,080) models of analysis with a risk of ischemic atherothrombotiс stroke. Intracranial hemorrhagic stroke manifestation associated with VNTR 4b/4a of eNOS3 gene polymorphism in codominant інтракраніального геморагічного інсульту, як показали кодомінантна (OR=2,509; 95 % CI:1,049-4,080), домінантна (OR = 2,977; 95 % CI:1,344–6,596) та мультиплікативна (OR=3,037; 95 % CI:1,529–6,030) моделі обрахунку. Комбінація генотипів 894GТ та 4b/4a гена eNOS3 із генотипом -148СТ гена FGB збільшувала, а комбінація генотипу -148СС гена FGB із генотипом -786СС гена eNOS3 зменшувала ризик розвитку ішемічного атеротромботичного інсульту. Висновки. Генетичне дослідження до маніфестації хвороби, особливо при спадковому обтяженні, може стати суттєвим інструментом у розробці індивідуальних профілактичних заходів, направлених на попередження розвитку гострих порушень мозкового кровообігу. Ключові слова: поліморфізм, бета фібриноген, NO-синтаза 3, ішемічний інсульт, геморагічний інсульт. Для цитування: Цимбалюк ВІ, Васильєва ІГ, Костюк МР, Чопик НГ, Галанта ОС, Цюбко ОІ, Олексенко НП, Дмитренко АБ, Макарова ТА, Шуба ІМ. Аналіз асоціації поліморфізмів генів FGB та eNOS3 із ризиком розвитку інтракраніального геморагічного та атеротромботичного ішемічного інсультів. Журнал Національної академії медичних наук України. 2019;25(4):389–96.